Stockmarket

Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company



© Reuters. Cathie Wood Trims Robinhood Stake As Stock Gains 28% In January — Also Offloads Shares In This Biotech Company

Benzinga – Cathie Wood-led ARK Investment Management sold 85,337 shares of financial services company Robinhood Markets Inc (NASDAQ: HOOD) at an estimated valuation of over $888,000 based on Tuesday’s closing price. The sale was done through the ARK Fintech Innovation ETF (NYSE: ARKF).

Robinhood is the seventh largest holding of the fund with a weight of 4.97%. ARK seems to have taken advantage of the recent rally in the markets to offload part of its holdings as the company’s shares gained over 28% since the beginning of 2023. Despite its recent rally, the stock is still down more than 28% over the past one-year period.

Also Read: How To Buy Stocks On Robinhood

Chart Patterns: The stock has support close to the $7.6 level and is hovering very close to its near-term resistance of $10.5. If it breaches this level on the upside, it is likely to move close to the $11.5 mark following which it faces a crucial resistance at the $12.48 level.

Options expiring on Feb. 3 indicate Robinhood stock faces stiff resistance all the way from the $10.5-$11.5 level during the week support comes in between $9.5-$10.

Source: Trading View

With the company scheduled to report its earnings on Feb. 8 and with the Federal Reserve set to announce its policy on Wednesday, the stock’s implied volatility is on the higher side, in line with the general market.

Major Sale: ARK also sold 48,505 shares of Exact Sciences Corp (NASDAQ: EXAS) at an estimated valuation of over $3.2 million based on Tuesday’s closing price. The sale was done via the ARK Genomic Revolution ETF (NYSE: ARKG).

Read Next: Tesla, Amazon, Apple, Context Therapeutics, Snap: Why These 5 Stocks Are Drawing Investors’ Attention Today

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.